A Phase 1b, 4-Period Crossover, Placebo-Controlled, Randomized, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-925 in Sleep-Deprived Healthy Adults Utilizing Modafinil as an Active Comparator
Phase of Trial: Phase I
Latest Information Update: 23 Nov 2018
At a glance
- Drugs TAK-925 (Primary) ; Modafinil
- Indications Narcolepsy
- Focus Therapeutic Use
- Sponsors Takeda
- 12 Nov 2018 Status changed from active, no longer recruiting to completed.
- 05 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 08 Jun 2018 Status changed from not yet recruiting to recruiting.